CORT(Corcept Therapeutics Incorporated) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $365.98M | $401.86M | $482.38M | $675.04M | $761.41M |
| 毛利润 | $360.70M | $396.47M | $475.89M | $664.16M | $748.43M |
| 营业利润 | $124.48M | $112.63M | $107.28M | $136.95M | $44.80M |
| 净利润 | $112.51M | $101.42M | $106.14M | $141.21M | $99.65M |
| 经营现金流 | $167.89M | $120.32M | $126.68M | $198.29M | $142.00M |
| 自由现金流 | $167.42M | $119.91M | $126.54M | $196.12M | $141.78M |
| 摊薄每股收益 | $0.89 | $0.87 | $0.94 | $1.23 | $0.82 |